title: Chelation therapy for secondary iron overload: is the primary effect less iron or less liver fibrosis?
authors.forename: Paul C
authors.initials: PC
authors.lastname: Adams
mesh_terms: D001565:Benzoates / Q000627:therapeutic use*; D000077588:Deferasirox; D005260:Female; D006801:Humans; D007502:Iron Chelating Agents / Q000627:therapeutic use*; D008099:Liver / Q000187:drug effects*; D008103:Liver Cirrhosis / Q000188:drug therapy*; D008297:Male; D014230:Triazoles / Q000627:therapeutic use*; D017086:beta-Thalassemia / Q000188:drug therapy*
chemical_list: D001565:Benzoates; D007502:Iron Chelating Agents; D014230:Triazoles; D000077588:Deferasirox